Professor Kim Young-gil of Soonchunhyang University Cheonan Hospital Wins Best Poster Award at the Korean Association of Hepato-Biliary-Pancreatic Surgery
"Survival Rate of Patients Undergoing Hepatectomy Higher Than That of Transarterial Chemoembolization"
Suncheonhyang University Cheonan Hospital announced on the 27th that Professor Kim Young-gil (36) from the Department of Surgery received the 'Best Poster Presentation Award' at the '2024 Korean Association of Hepato-Biliary-Pancreatic Surgery International Academic Conference and the 60th Regular Academic Conference.'
Professor Kim's research paper, "Survival benefit of liver resection comparing TACE for intermediate stage of HC," compared and analyzed the outcomes of liver resection and transarterial chemoembolization performed on patients with intermediate-stage liver cancer.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- [Breaking] Park Sukeun, Central Labor Relations Commission Chair: "Some Gaps Narrowed Between Samsung Electronics Labor and Management"
- Is This the Peak? As Others Hesitate..."The Answer Is Clear for Surviving the KOSPI 10,000 Era"
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
Professor Kim Young-gil stated, "Liver resection is mainly performed on patients with early-stage liver cancer, but this study proved its effectiveness in patients with intermediate-stage liver cancer as well," adding, "The analysis showed that patients who underwent liver resection had higher survival rates and better prognoses compared to those who received transarterial chemoembolization."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
